Tanaka Capital Management Inc / CORT
Tanaka Capital Management Inc’s Corcept Therapeutics Inc Position
Does Tanaka Capital Management Inc own Corcept Therapeutics Inc (CORT)? Yes — 110.9K shares worth $4M (+7.46% of its 13F portfolio) as of Q1 2026, down from 111.1K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
110.9K
% of Portfolio
+7.46%
Quarters Held
28
currently held
Position History CORT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 110.9K | $4M | +7.46% |
| Q4 2025 | 111.1K | $4M | +7.05% |
| Q3 2025 | 111.2K | $9M | +16.64% |
| Q1 2025 | 93.2K | $11M | +25.34% |
| Q4 2024 | 111.6K | $6M | +12.85% |
| Q3 2024 | 112.1K | $5M | +12.00% |
| Q2 2024 | 100.3K | $3M | +7.71% |
| Q1 2024 | 90.9K | $2M | +5.63% |
| Q4 2023 | 37.1K | $1M | +2.95% |
| Q3 2023 | 37.6K | $1M | +2.92% |
| Q2 2023 | 35.5K | $791,000 | +2.14% |
| Q1 2023 | 35.5K | $770,000 | +2.24% |
| Q4 2022 | 35.5K | $722,000 | +2.29% |
| Q3 2022 | 35.5K | $911,000 | +2.72% |
| Q2 2022 | 35.5K | $845,000 | +2.75% |
| Q1 2022 | 39.3K | $885,000 | +1.79% |
| Q4 2021 | 39.5K | $782,000 | +1.49% |
| Q3 2021 | 40.0K | $788,000 | +1.12% |
| Q2 2021 | 40.0K | $881,000 | +1.19% |
| Q1 2021 | 40.0K | $953,000 | +1.21% |
| Q4 2020 | 40.2K | $1M | +2.33% |
| Q3 2020 | 40.3K | $702,000 | +2.20% |
| Q2 2020 | 61.9K | $1M | +3.22% |
| Q1 2020 | 65.6K | $780,000 | +3.41% |
| Q4 2019 | 69.6K | $843,000 | +2.67% |
| Q3 2019 | 74.1K | $1M | +3.38% |
| Q2 2019 | 76.8K | $857,000 | +2.63% |
| Q1 2019 | 79.6K | $934,000 | +2.82% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tanaka Capital Management Inc’s full portfolio or all institutional holders of CORT.